Carotenuto Marco, Di Sessa Anna, Esposito Maria, Grandone Anna, Marzuillo Pierluigi, Bitetti Ilaria, Umano Giuseppina Rosaria, Precenzano Francesco, Miraglia Del Giudice Emanuele, Santoro Nicola
Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, University of Campania "Luigi Vanvitelli", 80100 Naples, Italy.
Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Children (Basel). 2021 Nov 1;8(11):984. doi: 10.3390/children8110984.
Owing to the increasing rate of pediatric obesity, its complications such as non-alcoholic fatty liver disease (NAFLD) and obstructive sleep apnea (OSA) have become prevalent already in childhood. We aimed to assess the relationship between these two diseases in a cohort of children with obesity.
We enrolled 153 children with obesity (mean age 10.5 ± 2.66, mean BMI 30.9 ± 5.1) showing OSA. Subjects underwent a laboratory evaluation, a cardio-respiratory polysomnography (PSG), and a liver ultrasound.
All subjects had a clinical diagnosis of OSA based on the AHI > 1/h (mean AHI 8.0 ± 5.9; range 2.21-19.0). Of these, 69 showed hepatic steatosis (62.3% as mild, 20.3% as moderate, and 17.4% as severe degree). A strong association between ALT and apnea/hypopnea index (AHI) was observed ( = 0.0003). This association was not confirmed after adjusting for hepatic steatosis ( = 0.53). By subdividing our population according to the presence/absence of steatosis, this association was found only in the steatosis group ( = 0.009). As the severity of steatosis increased, the significance of its association with AHI compared to the absence of steatosis became progressively stronger (all < 0.0001).
Hepatic steatosis seems to drive the association between OSA and ALT levels, suggesting a potential pathogenic role of OSA in NAFLD.
由于儿童肥胖率不断上升,其并发症如非酒精性脂肪性肝病(NAFLD)和阻塞性睡眠呼吸暂停(OSA)在儿童期已很普遍。我们旨在评估肥胖儿童队列中这两种疾病之间的关系。
我们纳入了153名患有阻塞性睡眠呼吸暂停的肥胖儿童(平均年龄10.5±2.66岁,平均BMI 30.9±5.1)。受试者接受了实验室评估、心肺多导睡眠图(PSG)和肝脏超声检查。
所有受试者根据呼吸暂停低通气指数(AHI)>1次/小时均有阻塞性睡眠呼吸暂停的临床诊断(平均AHI 8.0±5.9;范围2.21 - 19.0)。其中,69例显示肝脂肪变性(轻度占62.3%,中度占20.3%,重度占17.4%)。观察到丙氨酸氨基转移酶(ALT)与呼吸暂停/低通气指数(AHI)之间存在强关联(P = 0.0003)。在调整肝脂肪变性后,这种关联未得到证实(P = 0.53)。根据是否存在脂肪变性对我们的人群进行细分后,仅在脂肪变性组中发现了这种关联(P = 0.009)。随着脂肪变性严重程度的增加,与无脂肪变性相比,其与AHI关联的显著性逐渐增强(所有P < 0.0001)。
肝脂肪变性似乎推动了阻塞性睡眠呼吸暂停与ALT水平之间的关联,提示阻塞性睡眠呼吸暂停在非酒精性脂肪性肝病中可能具有致病作用。